v3.26.3
Other Non-Marketable Equity Securities - Schedule of Other Non-Marketable Equity Securities (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Other Non-Marketable Equity Securities [Line Items]    
Other non-marketable equity securities $ 4,424 $ 3,624
Diasome [Member]    
Other Non-Marketable Equity Securities [Line Items]    
Other non-marketable equity securities 3,524 3,524
Hopec Pharma Ltd. [Member]    
Other Non-Marketable Equity Securities [Line Items]    
Other non-marketable equity securities [1] 500
Other [Member]    
Other Non-Marketable Equity Securities [Line Items]    
Other non-marketable equity securities $ 400 $ 100
[1]  (1)Hopec Pharma Ltd.

 

In May 2026, the Company entered into a Simple Agreement for Future Equity (the “SAFE”) with Hopec Pharma Ltd. (“Hopec”), pursuant to which the Company agreed to invest up to $1,000 in Hopec. The Company invested $500 upon entering into the SAFE and, at the Company’s discretion, may invest an additional $500 following receipt of written notice of the successful results from the Week 14 cystoscopy assessment of the third patient in the first cohort of Hopec’s clinical study.